Streptomycin inhibits quorum sensing in Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1926-1929

  Saroj, Sunil D ^a   Rather, Philip N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N ACYLHOMOSERINE LACTONE; STREPTOMYCIN;

ABAI GENE; ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; CONCENTRATION (PARAMETERS); GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; THIN LAYER CHROMATOGRAPHY;

ACINETOBACTER BAUMANNII; ACYL-BUTYROLACTONES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CHROMATOGRAPHY, THIN LAYER; QUORUM SENSING; STREPTOMYCIN;

EID: 84875192937     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02161-12     Document Type: Article

References (33)

1. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Doughari HJ, Ndakidemi PA, Human IS, Benade S. 2011. The ecology, biology and pathogenesis of Acinetobacter spp.: an overview. Microbes Environ. 26:101-112.
3. Joly-Guillou ML. 2005. Clinical impact and pathogenicity of Acinetobacter. Clin. Microbiol. Infect. 11:868-873.
4. Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat. Rev. Microbiol. 5:939-951.
5. Perez F, Hujer AMKM, Hujer Decker BK, Rather PN, Bonomo RA. 2007. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51:3471-3484.
6. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, Richet H. 1998. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Ann. Intern. Med. 129:182-189.
7. Antunes LC, Imperi F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6:e22674. doi:10.1371/journal.pone.0022674.
8. Cerqueira GM, Peleg AY. 2011. Insights into Acinetobacter baumannii pathogenicity. IUBMB Life 63:1055-1060.
9. Gaddy JA, Actis LA. 2009. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 4:273-278.
10. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. 21:538-582.
11. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. 2003. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149:3473-3484.
12. de Kievit TR, Iglewski BH. 2000. Bacterial quorum sensing in pathogenic relationships. Infect. Immun. 68:4839-4849.
13. Miller MB, Bassler BL. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165-199.
14. Niu C, Clemmer KM, Bonomo RA, Rather PN. 2008. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J. Bacteriol. 190:3386-3392.
15. Clemmer KM, Bonomo RA, Rather PN. 2011. Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 157:2534-2544.
16. Anbazhagan D, Mansor M, Yan GO, Md Yusof MY, Hassan H, Sekaran SD. 2012. Detection of quorum sensing signal molecules and identification of an autoinducer synthase gene among biofilm forming clinical isolates of Acinetobacter spp. PLoS One 7:e36696. doi:10.1371/journal.pone.0036696.
17. Barker J, Maxted H. 1975. Observations on the growth and movement of Acinetobacter on semi-solid media. J. Med. Microbiol. 8:443-446.
18. Eijkelkamp BA, Stroeher UH, Hassan KA, Papadimitrious MS, Paulsen IT, Brown MH. 2011. Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol. Lett. 323:44-51.
19. Henrichsen J. 1984. Not gliding but twitching motility of Acinetobacter calcoaceticus. J. Clin. Pathol. 37:102-103.
20. McQueary CN, Kirkup BC, Si Y, Barlow M, Actis LA, Craft DW, Zurawski DV. 2012. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface associated motility. J. Microbiol. 50:434-443.
21. Mussi MA, Gaddy JA, Cabruja M, Arivett BA, Viale AM, Rasia R, Actis LA. 2010. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J. Bacteriol. 192:6336-6645.
22. Skiebe E, de Berardinis V, Morczinek P, Kerrinnes T, Faber F, Lepka D, Hammer B, Zimmermann O, Ziesing S, Wichelhaus TA, Hunfeld KP, Borgmann S, Grobner S, Higgins PG, Seifert H, Busse HJ, Witte W, Pfeifer Y, Wilharm G. 2012. Surface associated motility, a common trait of clinical isolates of Acinetobacter baumannii depends on 1,3 diaminopropane. Int. J. Med. Microbiol. 302:117-128.
23. Harshey RM. 2003. Bacterial motility on a surface: many ways to a common goal. Annu. Rev. Microbiol. 57:249-273.
24. Josenhans C, Suerbaum S. 2002. The role of motility as a virulence factor in bacteria. Int. J. Med. Microbiol. 291:605-614.
25. Shi W, Sun H. 2002. Type IV pilus-dependent motility and its possible role in bacterial pathogenesis. Infect. Immun. 70:1-4.
26. Saroj SD, Clemmer KM, Bonomo RA, Rather PN. 2012. Novel mechanism for fluoroquinolone resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 56:4955-4957.
27. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K, Van Delden C. 2001. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chem. 45:1930-1933.
28. Curran HR, Evans FR. 1947. Stimulation of sporogenic and nonsporogenic bacteria by traces of penicillin or streptomycin. Proc. Soc. Exp. Biol. Med. 64:231-233.
29. Davies J, Gilbert W, Gorini L. 1964. Streptomycin, suppression, and the code. Proc. Natl. Acad. Sci. U. S. A. 51:883-890.
30. Davies J, Gorini L, Davis BD. 1965. Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol. Pharmacol. 1:93-106.
31. Davies J, Cannon M, Mauer MB. 1988. Myomycin: mode of action and mechanisms of resistance. J. Antibiot. 41:366-372.
32. Bryan LE, Kwan S. 1983. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23:835-845.
33. Kornder JD. 2002. Streptomycin revisited: molecular action in the microbial cell. Med. Hypotheses 58:34-46.